LINDSEY STEVENS: Open Payments
NPI 1578248613 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 7 payments from 6 companies in 2025. Trend: 2023 $174 · 2024 $329 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 1 | $150 |
| E.R. Squibb & Sons, L.L.C. | 1 | $115 |
| JAZZ PHARMACEUTICALS INC. | 2 | $67 |
| Daiichi Sankyo Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Genentech USA, Inc. | 1 | $14 |
Products named: PROVENGE, BREYANZI, ZEPZELCA, Vanflyta, IMFINZI, Polivy.
Industry payments across TX — which companies pay providers there.
